Jf. Maillefert et al., PREVALENCE OF ANCA IN A HOSPITALIZED ELDERLY FRENCH POPULATION, Clinical and experimental rheumatology, 15(6), 1997, pp. 603-607
Objective. The prevalence of some autoantibodies in the elderly popula
tion has been reported to be greater than in younger controls. The pre
valence of ANCA has been shown to be low in a generally healthy popula
tion, but has not been established in the elderly Thus, the presence o
f ANCA in elderly patients might not have the same clinical significan
ce as in younger people. The aim of this study was to evaluate the pre
valence of ANCA in elderly subjects. Patients and methods. Serum sampl
es from 137 subjects (96 females, 41 males; mean age = 82.2 years +/-
6.97 SD) were evaluated. Criteria for exclusion included suspected or
established system ic vasculitis, connective tissue or neoplastic dise
ases, acute infection, HN infection, current therapy with corticostero
ids or cytotoxic drugs, and recent blood transfusion. ANCA were detect
ed by indirect immunofluorescence on ethanol-fixed normal human neutro
phils. Fluorescence patterns were classified as c-ANCA, p-ANCA or nucl
ear Sera exhibiting p-ANCA or nuclear fluorescence Mere further tested
by IIF on formalin-acetone fixed normal human neutrophils. Sera whose
reaction pattern was cytoplasmic were considered as positive for ''tr
ue'' pANCA. Additionally, sera were tested for the presence of antinuc
lear antibodies (IIF), anti-double-stranded DNA (enzyme immunoassay) a
nd IgM rheumatoid factors (enzyme immunoassay). Results. The prevalenc
e of c-ANCA was 0% (95% CI = 0 - 2.66), the prevalence of p-ANCA was 2
.2% (95% CI = 0.45 - 6.3), and the prevalence of ''true'' p-ANCA was 0
.73% (95% CI = 0.02 - 4). The prevalence of ANA, anti ds-DNA and RF we
re respectively 38%, 3.6%, and 11.7%. Conclusion. The prevalence of AN
CA is not increased in elderly people. Thus, the presence of ANCA in e
lderly subjects may have the same clinical significance as in younger
people.